Previous product
Back to products
Ayvakit (avapritinib)
CHF45,500.00
Next product
Sarclisa (isatuximab)
CHF1,348.75
Pemazyre (pemigatinib)
CHF38,050.29
Pemazyre (pemigatinib) is a medication used for the treatment of adult patients with bile duct cancer (cholangiocarcinoma) that has spread or cannot be removed by surgery.
Reviews
There are no reviews yet.